Treatment of patients with fibromyalgia syndrome using the Rességuier and Qi Gong methods

INTERVENTION: 30 FMS patients are recruited and randomly assigned to the Group A and Group B. Group A: 15 patients, treated firstly with RM for 7 weeks (two sessions per week in the first 3 weeks and once per week in weeks 4‐7 = total of 10 sessions). After a 1‐week break, patients are treated with QG for 7 weeks (two sessions per week in the first 3 weeks and once per week in weeks 4‐7 = total of 10 sessions). Group B: 15 patients, treated firstly with QG for 7 weeks (two sessions per week in the first 3 weeks and once per week in weeks 4‐7 = total of 10 sessions). After a 1‐week break, patients are treated with RM for further 7 weeks (two sessions per week in the first 3 weeks and once per week in weeks 4‐7 = total of 10 sessions). Total duration of the study: 27 weeks, divided into 15 weeks of intervention (7 weeks for each method, with an interval of 1 week between the two techniques) and 12 weeks of follow up. All patients are assessed at baseline (T0), at the end of treatment (week 15: T1) and after 12 weeks of follow‐up (week 27: T2). CONDITION: Fibromyalgia syndrome ; Musculoskeletal Diseases ; Fibromyalgia PRIMARY OUTCOME: The following items are assessed at baseline (T0), at end of the first (week 7: T1) and the second treatment (week 15: T2) and after 9 weeks of follow‐up (week 27: FU):; 1. Pain assessed by regional pain scale (RPS); 2. Disability assessed by Fibromyalgia Impact Questionnarie (FIQ) and Health Assessment Questionnaire (HAQ) SECONDARY OUTCOME: The following items are assessed at baseline (T0), at end of the first (week 7: T1) and the second treatment (week 15: T2) and after 9 weeks of follow‐up (week 27: FU):; 1. Tenderness in specific FMS sites (by the tender points evaluation); 2. Quality of life by Medical Outcomes Survey Short Form 36 (SF‐36); 3. Anxiety and Depression by Hospital Anxiety and Depression Scale (HADS), with subscales for anxiety (HADS‐a) and depression (HADS‐d); 4. Quality of sleep by a number rating scale 0?10 (NRS‐ 0?10) INCLUSION CRITERIA: Diagnosis of fibromyalgia syndrome according to the American College of Rheumatology (ACR) criteria